3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Cardiovascular Diseases
1
Arthritis, Rheumatoid
1
Interventions
Adalimumab
10
Etanercept
9
Methotrexate
4
Infliximab
3
tofacitinib
2
Rituximab
2
Leflunomide
2
Abatacept
2
tocilizumab
1
sarilumab
1
golimumab
1
entecavir
1
Tumor Necrosis Factor Inhibitors
1
Sulfasalazine
1
Prednisone
1
Licensure
1
Hydroxychloroquine
1
Glucocorticoids
1
Folic Acid
1
Chloroquine
1
Certolizumab Pegol
1
Azathioprine
1
Antirheumatic Agents
1
Anti-Inflammatory Agents, Non-Steroidal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Arthritis, Rheumatoid
×
Antirheumatic Agents
×
Clear all
NCT01548768
2020-11-27
RHYTHM
Columbia University
Phase 4
Completed
149 enrolled
15 charts